novartis oncology and siemens healthineers on equalising cancer care
Published 3 years ago • 200 plays • Length 20:05Download video MP4
Download video MP3
Similar videos
-
2:15:27
bloomberg prognosis: reshaping cancer care
-
1:13
novartis cancer drug is approved with $475,000 price tag
-
2:41
siemens healthineers ceo bernd montag on the future of ai and machine learning in medicine
-
2:15
a leap in cancer care – a leap in impact
-
3:56
the future of cancer treatment is here: introducing proton therapy
-
25:17
novartis ceo vas narasimhan: how to be a boss in an “unbossed” company
-
4:34
next generation scientist 2024
-
4:22
novartis ceo on new cancer therapy programs
-
4:54
novartis ceo: confident about continued sales growth for rest of year
-
0:44
ending the pandemic – how novartis supports the global vaccine supply
-
0:35
meet kathrin, austria based head operational manufacturing
-
3:49
manufacturing potentially life-changing biosimilars for patients during covid-19
-
1:13
novartis celebrates 34 years in singapore
-
2:01
be healthy: the first company-wide health and well-being initiative at novartis
-
0:31
svmc cancer center novalis tx radio surgery
-
3:02
ai in cancer care: how it changes radiation therapy
-
1:10
reimagining cancer and blood disorders
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
0:39
marcel, maintenance leader at novartis in austria